Dr. Lawrence Tsai , MD
Urology โข Austin, TX
11645 Angus Rd Ste B9
Austin, TX 787594100
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 14, 2014; this date does not establish years in practice.
-
Published CMS data list 4,100 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0585 โ Injection, onabotulinumtoxina, 1 unit: 2,400 service units.
- 51798 โ Ultrasound measurement of bladder capacity after voiding: 313 service units.
- 99213 โ Established patient outpatient office visit: 266 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 20 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 532 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl โ 169 prescription fills, including refills.
- Ciprofloxacin Hcl โ 47 prescription fills, including refills.
- Finasteride โ 37 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: 4,072. Middle half: 1,074 to 6,811.
More Medicare Part B services than 70% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 662 in 2020 to 4,100 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
11645 Angus Rd Ste B9
Austin, TX 787594100
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Austin, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Texas Oncology Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas A & M University System, Hsc, College Of Medicine
2014
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
420 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $193,253 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $145,860 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,048 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$59,484 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $410.93 across 21 records.
By nature of payment
- Food and Beverage: $410.93 across 21 records.
Reporting-company totals (3 largest of 10)
- ABBVIE INC.: $135.40 across 9 records.
- Sumitomo Pharma America, Inc.: $68.72 across 3 records.
- Teleflex LLC: $50.02 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
12 years (graduated 2014)
CMS Doctors and Clinicians data list 2014 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2014
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Tsai has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Tsai as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: 4,072. Middle half: 1,074 to 6,811.
More Medicare Part B services than 70% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Medicare-allowed amount
Close to the middle for clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: $200,192. Middle half: $89,956 to $268,588.
A higher Medicare-allowed amount than 65% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Paid by Medicare
Close to the middle for clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: $148,342. Middle half: $66,664 to $197,998.
A higher Medicare payment amount than 65% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Urology in Austin, TX (2024, 35 clinicians with data). Median for this group: 950. Middle half: 457 to 2,182.
Fewer Part D prescriptions than 70% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under Urology in Austin, TX (2024, 35 clinicians with data). Median for this group: $250,675. Middle half: $46,030 to $485,105.
A lower Part D drug cost than 65% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
43 active clinicians are listed under Urology with a practice address in Austin, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
60.5% of these 43 clinicians have the CMS telehealth indicator.
74.4% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 519% from 662 in 2020 to 4,100 in 2024.
- 2020: 662
- 2021: 2,994
- 2022: 3,773
- 2023: 2,875
- 2024: 4,100
-
Medicare-allowed amount
Medicare-allowed amount increased 133% from $82,950 in 2020 to $193,253 in 2024.
- 2020: $82,950
- 2021: $176,081
- 2022: $143,430
- 2023: $131,179
- 2024: $193,253
-
Paid by Medicare
Paid by Medicare increased 124% from $65,188 in 2020 to $145,860 in 2024.
- 2020: $65,188
- 2021: $136,270
- 2022: $107,054
- 2023: $101,249
- 2024: $145,860
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 18% from 449 in 2020 to 532 in 2024.
- 2020: 449
- 2021: 661
- 2022: 454
- 2023: 282
- 2024: 532
-
30-day fills
30-day fills increased 103% from 516 in 2020 to 1,048 in 2024.
- 2020: 516
- 2021: 841
- 2022: 618
- 2023: 442
- 2024: 1,048
-
Part D drug cost
Part D drug cost increased 355% from $13,080 in 2020 to $59,484 in 2024.
- 2020: $13,080
- 2021: $16,297
- 2022: $10,750
- 2023: $15,908
- 2024: $59,484
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $990.79 in 2021 to $410.93 in 2025.
- 2021: $990.79
- 2022: $1,439.34
- 2023: $958.80
- 2024: $537.89
- 2025: $410.93
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 21 records totaling $410.93.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $31.50 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $28.57 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
UROLIFT | General | $27.30 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $26.16 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $25.99 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $24.95 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.87 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $23.17 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $22.72 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $22.48 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $21.47 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $21.15 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.68 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $19.03 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $17.03 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $16.24 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $9.56 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $9.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $7.27 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $6.72 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $5.07 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0585
Injection, onabotulinumtoxina, 1 unit
|
2,400 | 17 | $16.00 | $6.25 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
313 | 193 | $97.00 | $11.26 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
266 | 188 | $250.00 | $89.30 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
250 | 164 | $368.00 | $125.71 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
141 | 141 | $565.00 | $162.63 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
103 | 95 | $684.00 | $239.98 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
102 | 92 | $35.00 | $15.79 |
|
81003
Automated urinalysis test
|
89 | 67 | $16.00 | $2.20 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
76 | 20 | $36.00 | $0.44 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
58 | 58 | $372.00 | $110.31 |
|
96372
Injection of drug or substance under skin or into muscle
|
52 | 12 | $96.00 | $14.40 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
45 | 41 | $1114.00 | $368.19 |
|
51741
Electronic assessment of bladder emptying
|
44 | 41 | $277.00 | $7.01 |
|
76872
Ultrasound scan of pelvic region through rectum
|
43 | 43 | $431.00 | $135.76 |
|
52649
Complete laser fragmentation of prostate including control of bleeding using an endoscope
|
28 | 28 | $2963.00 | $789.75 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
27 | 27 | $470.00 | $126.67 |
|
52287
Exam with injections of chemical for destruction of bladder using an endoscope
|
23 | 17 | $1029.00 | $392.40 |
|
52332
Insertion of stent in ureter using an endoscope
|
14 | 12 | $2046.00 | $130.96 |
|
55700
Biopsy of prostate gland
|
13 | 13 | $775.00 | $234.11 |
|
76942
Ultrasonic guidance for needle placement
|
13 | 13 | $633.00 | $58.60 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 169 | 12,330 | $1,818.19 | 81 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 420 | $152.09 | 29 |
| Finasteride | Finasteride | 37 | 2,850 | $527.78 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 36 | 141 | $186.00 | 26 |
| Testosterone Cypionate | Testosterone Cypionate | 34 | 2,027 | $2,679.34 | 16 |
| Gemtesa | Vibegron | 34 | 1,956 | $30,396.65 | 16 |
| Cefdinir | Cefdinir | 28 | 427 | $566.90 | 16 |
| Myrbetriq | Mirabegron | 25 | 1,410 | $20,859.82 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 24 | 2,160 | $533.29 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 224 | $240.36 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 328 | $68.35 | 18 |
| Estradiol | Estradiol | 17 | 1,766 | $1,048.00 | 16 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | 229 | $118.18 | 13 |
| Cephalexin | Cephalexin | 13 | 315 | $55.88 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | 990 | $233.06 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-11-21NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20190729003490
TX
9931480035
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Texas Oncology Pa
901 W 38th St, Austin, TX 787051165
Phone: 5124214100
Secondary Practice Locations
12319 N Mopac Expy Ste 200
Austin, TX 787582497
Phone: 5129738276
901 W 38th St Ste 200
Austin, TX 787051165
Phone: 5124214235
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Surgery
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Radiology - Radiation Oncology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant
Internal Medicine - Medical Oncology
Doctor of Medicine (M.D.)
Physical Therapist
Physical Therapist, Certified Lymphedema Therapist
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11645 ANGUS RD STE B9, AUSTIN, TX 787594100 (Tel: 5124214235)
Registered at PO BOX 911230, DALLAS, TX 753911230 (Tel: 9729978000)
Registered at 12319 N MOPAC EXPY STE 200, AUSTIN, TX 787582497 (Tel: 5129738276)
Registered at 12319 N MOPAC EXPY STE 200, AUSTIN, TX 787582497 (Tel: 2549136542)
Urology (license number reported to NPPES: TX S1004)
NPI status registered as active in NPPES database
Registered at 2401 S 31ST ST, TEMPLE, TX 765080001 (Tel: 2547242111)
Registered at 2627 BUTTERFLY DR, TEMPLE, TX 765027918 (Tel: 2549136542)
Recorded as LAWRENCE TSAI, M.D.
Urology (license number reported to NPPES: TX BP10051000)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Austin
- Dr. Michael Trotter, MD
- Dr. Melody Denson, MD
- Dr. Jeffrey Kocurek, MD
- Dr. David Dalton, MD
- Dr. Kyle Keyes, MD
- Dr. Subir Chhikara, MD
Mailing Address
Po Box 911230
Dallas, TX 753911230
Phone: 9729978000